Making the value of technology clear
IoT Medical Device Monitoring (Buyer’s Guide)What should Life Sciences companies look for in a solution to help them simultaneously improve profitability and patient outcomes using remote device monitoring via the IoT? Our new Improving Service Performance and Patient Outcomes with Remote Monitoring Buyer’s Guide helps Life Sciences companies understand the business and social value of monitoring equipment with the IoT.
Preparing for EU MDR (eBook)Are you ready for the EU MDR? Tech-Clarity’s Preparing for EU MDR explains the impact of the EU MDR on your product data. While complying to the EU MDR may require an investment, taking the steps now to prepare your product data will not only support EU MDR compliance, but will position your company to
Remote Monitoring Solution Selection for Medical Device Service (webcast)What should Life Sciences Companies look for in a solution to transform service using IoT remote monitoring? Tech-Clarity’s Jim Brown and PTC’s Anthony Moffa will share recent research and industry experience on this Medical Design & Outsourcing webcast, How to Select a Remote Monitoring Solution to Transform Your Service Model. The webcast will cover how
EU MDR: How Abbott is Getting Their Digital House In Order (webcast)If you are in the medical device industry, are you prepared for the EU MDR? On Tuesday, November 6 at 2:00 EST, Tech-Clarity’s Michelle Boucher will interview Caroline Byrd, regulatory expert at Abbott, about the steps Abbott has taken to prepare product data for EU MDR compliance. They will discuss: Significant changes between the MDD
Translating Digital Buzzwords to Real Value for Medical Devices (post)Tech-Clarity research shows that the majority of manufacturers believe that digitalization is important or critical to achieving their business strategy (see figure). Over one-third say that it’s critical. Digitalization in medical device design and manufacturing has significant promise, but what does it actually mean? Medical device companies, already struggling with how to address critical initiatives
Would greater regulatory support for in silico clinical trials help you? What are best practices to support personalized healthcare? How are other companies using in silico clinical trials and what benefits do they see? We are conducting new research on the healthcare industry to explore these questions and more. If you work in the healthcare industry,
